MediWound (MDWD) Cash from Operations (2013 - 2026)
MediWound (MDWD) posted Cash from Operations of -$9.1 million for Q2 2026, down 35.13% on a QoQ basis from -$6.8 million in Q1 2026, and down 58.56% year-over-year from -$22.0 million in Q2 2025.
Powered by 
Analysis
MediWound (MDWD) Cash from Operations (2013 - 2026) Analysis & Trends
MediWound has reported Cash from Operations for 14 years, with the latest figure at -$9.1 million in Q2 2026.
- On a quarterly basis, Cash from Operations fell 58.56% year-over-year to -$9.1 million in Q2 2026; TTM through Jun 2026 was -$22.1 million, a 45.07% decrease from a year earlier, with the FY2025 full-year figure at -$16.1 million, down 18.33% from the prior year.
- Cash from Operations was -$9.1 million for Q2 2026 at MediWound, down from -$6.8 million in the prior quarter.
- The five-year high for Cash from Operations was $750000.0 in Q4 2022, with the low at -$9.1 million in Q2 2026.
- Average Cash from Operations over 5 years is -$3.8 million, with a median of -$3.8 million recorded in 2024.
- The sharpest annual moves came in 2022 and 2024: Cash from Operations surged 133.56% in 2022, then sank 806.75% in 2024.
- Over 5 years, Cash from Operations stood at $750000.0 in 2022, then plunged by 448.67% to -$2.6 million in 2023, then soared by 37.4% to -$1.6 million in 2024, then tumbled by 84.24% to -$3.0 million in 2025, then plunged by 202.62% to -$9.1 million in 2026.
- The last three Cash from Operations figures came in at -$9.1 million (Q2 2026), -$6.8 million (Q1 2026), and -$3.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 4.00 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 3.57 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 1.13 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 813.00 Mn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | -526.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 326.72 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 448.90 Mn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | -270.50 Mn |
| 10 | MediWound | 156.09 Mn | 120.75 Mn | 337,000.00 | -9.13 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -9.13 Mn |
| Mar 31, 2026 | -6.75 Mn |
| Dec 31, 2025 | -3.02 Mn |
| Sep 30, 2025 | -3.24 Mn |
| Jun 30, 2025 | -5.76 Mn |
| Mar 31, 2025 | -4.11 Mn |
| Dec 31, 2024 | -1.64 Mn |
| Sep 30, 2024 | -3.76 Mn |
| Jun 30, 2024 | -3.62 Mn |
| Mar 31, 2024 | -4.61 Mn |
| Dec 31, 2023 | -2.62 Mn |
| Sep 30, 2023 | -3.25 Mn |
| Jun 30, 2023 | -5.25 Mn |
| Mar 31, 2023 | 652,000.00 |
| Dec 31, 2022 | 750,000.00 |
| Jun 30, 2022 | -5.25 Mn |
| Mar 31, 2022 | -4.07 Mn |
| Dec 31, 2021 | -2.24 Mn |
| Sep 30, 2021 | -2.82 Mn |
| Jun 30, 2021 | -985,000.00 |